EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

The Impact of Access to Clinical Guidelines on LLM‐Based Treatment Recommendations for Chronic Hepatitis B

Robert Siepmann iD, Carolin Victoria Schneider iD, Marc Sebastian von der Stueck, Iakovos Amygdalos, Karsten Große, Kai Markus Schneider, Maike Rebecca Pollmanns, Mohamad Murad, Joel Joy, Elena Kabak, Marcella Ricardis May, Jan Clusmann und 4 weitere

Liver International · 2025-10 · 45 (10)

DOI: 10.1111/liv.70324 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Liver International, online erschienen am 02.09.2025. Verfasst von Robert Siepmann und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Aachen, Germany. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Practice Guidelines as Topic, Antiviral Agents, Language. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Federal Ministry of Research, Technology and Space, Deutsche Forschungsgemeinschaft, European Union Research and Innovation Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Large language models (LLMs) can potentially support clinicians in their daily routine by providing easy access to information. Yet, they are plagued by stating incorrect facts and hallucinating when queried. Increasing the context by providing external databases while prompting LLMs may decrease the risk of misinformation. This study compares the influence of increased context on the coherence of LLM‐based treatment recommendations with the recently updated WHO guidelines for the treatment of chronic hepatitis B (CHB).

Methods

GPT‐4 was queried with five clinical case vignettes in two configurations: with and without additional context. The clinical vignettes were explicitly constructed so that treatment recommendations differed between the formerly applicable 2015 WHO guidelines and the updated 2024 ones. GPT‐4 with context was provided access to the updated guidelines, while GPT‐4 without context had to rely on its internal knowledge. GPT‐4 was accessed only a few days after the release of the new WHO guidelines. Treatment recommendations were compared regarding guideline coherence, information inclusion, textual errors, wording clarity and preciseness by seven physicians.

Results

Using GPT‐4 with context increased the coherence of the treatment recommendations with the new 2024 guidelines from 51% to 91% compared to GPT‐4 without context. Similar trends were observed for all other categories, leading to an increase of 54% in preciseness and clarity, 24% in completeness of incorporating the case vignette information, and 12% in textual correctness.

Conclusions

If LLMs are consulted by clinicians for medical advice, they should be given access to external data sources to increase the chance of providing factually correct advice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicPractice Guidelines as TopicAntiviral AgentsLanguageAccess to InformationHumansWorld Health OrganizationFemaleMaleAdultMiddle Aged

Stichwörter der Autor:innen

GPTLLMchronic hepatitis Bguideline coherence

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Aachen, Germany.
  • Department of Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Aachen, Germany.
  • Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.
  • Else Kroener Fresenius Center for Digital Health, Medical Faculty Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
  • Department of Medicine 1, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

ORCID-Profile: Robert Siepmann, Carolin Victoria Schneider, Sven Nebelung

Förderung

  • German Federal Ministry of Research, Technology and Space
  • Deutsche Forschungsgemeinschaft
  • European Union Research and Innovation Programme

Zitieren

APA

Siepmann, R., Schneider, C. V., von der Stueck, M. S., Amygdalos, I., Große, K., Schneider, K. M., Pollmanns, M. R., Murad, M., Joy, J., Kabak, E., May, M. R., Clusmann, J., Kuhl, C., Nebelung, S., Kather, J. N., & Truhn, D. (2025). The Impact of Access to Clinical Guidelines on LLM‐Based Treatment Recommendations for Chronic Hepatitis B. Liver International, 45(10). https://doi.org/10.1111/liv.70324

Vancouver

Siepmann R, Schneider CV, von der Stueck MS, Amygdalos I, Große K, Schneider KM, et al. The Impact of Access to Clinical Guidelines on LLM‐Based Treatment Recommendations for Chronic Hepatitis B. Liver International. 2025;45(10). doi:10.1111/liv.70324

BibTeX
@article{Siepmann2025,
  author = {Siepmann, Robert and Schneider, Carolin Victoria and von der Stueck, Marc Sebastian and Amygdalos, Iakovos and Große, Karsten and Schneider, Kai Markus and Pollmanns, Maike Rebecca and Murad, Mohamad and Joy, Joel and Kabak, Elena and May, Marcella Ricardis and Clusmann, Jan and Kuhl, Christiane and Nebelung, Sven and Kather, Jakob Nikolas and Truhn, Daniel},
  title = {The Impact of Access to Clinical Guidelines on LLM‐Based Treatment Recommendations for Chronic Hepatitis B},
  journal = {Liver International},
  year = {2025},
  volume = {45},
  number = {10},
  doi = {10.1111/liv.70324}
}
Kostenlos starten →